Do standardized beta-blocker titration protocols in heart failure improve compliance? The GESICA registry experience.
Remme
Willem J
WJ
D000319:Adrenergic beta-Antagonists / Q000009:adverse effects / Q000592:standards* / Q000627:therapeutic use*; D001794:Blood Pressure / Q000187:drug effects; D002227:Carbazoles / Q000009:adverse effects / Q000592:standards* / Q000627:therapeutic use*; D000077261:Carvedilol; D006333:Heart Failure / Q000188:drug therapy* / Q000503:physiopathology; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D010349:Patient Compliance; D011412:Propanolamines / Q000009:adverse effects / Q000592:standards* / Q000627:therapeutic use*; D013318:Stroke Volume / Q000187:drug effects; D018487:Ventricular Dysfunction, Left / Q000188:drug therapy / Q000503:physiopathology; D016277:Ventricular Function, Left / Q000187:drug effects
D000319:Adrenergic beta-Antagonists; D002227:Carbazoles; D011412:Propanolamines; D000077261:Carvedilol